載入...
Conjugate of Doxorubicin to Albumin-Binding Peptide Outperforms Aldoxorubicin
Short circulation time and off-target toxicity are the main challenges faced by small-molecule chemotherapeutics. To overcome these shortcomings, an albumin-binding peptide conjugate of chemotherapeutics is developed that binds specifically to endogenous albumin and harnesses its favorable pharmacok...
Na minha lista:
| 發表在: | Small |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8114561/ https://ncbi.nlm.nih.gov/pubmed/30756483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201804452 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|